SCHEMBL29992015

SCHEMBL29992015

CC(C)(C)OC(=O)N1CCC(Nc2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.69
NPC1 O15118 2/20 0.69
RAB9A P51151 2/20 0.69
MAPT P10636 1/20 0.69
MAPK1 P28482 1/20 0.69
HTT P42858 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
PTPN2 P17706 1/20 0.53
PTPN1 P18031 1/20 0.53
PTPN6 P29350 1/20 0.53
CNR1 P21554 2/20 0.50
STS P08842 2/20 0.50
F13A1 P00488 1/20 0.50
TGM2 P21980 1/20 0.50
TGM1 P22735 1/20 0.50
TGM3 Q08188 1/20 0.50
DDB1 Q16531 1/20 0.50
CRBN Q96SW2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL331157 0.93 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL331158 0.93 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL18269412 0.91 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL31065806 0.90 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13159519 0.90 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13158356 0.90 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL2576635 0.89 ALDH1A1 (0.55) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6153856 0.89 ALDH1A1 (0.64) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL12041869 0.89 MAPT (0.64) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6155117 0.88 ALDH1A1 (0.62) ALDH1A1NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518756-B2 Arylation method UMICORE AG & CO. KG (DE) 2022-12-06 US claimed
US-11518756-B2 Arylation method UMICORE AG & CO. KG (DE) 2022-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518756-B2 Arylation method AHR, ARNT, CYP2B6 ALDH1A1 216/4885NPC1 1464/4885RAB9A 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.